# US 2005/0032740 A1 · Vitamin compositions for the treatment and prevention of vascular disease and dementia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0032740 A1
- Document ID: US20050032740A1
- Status: Published application
- Kind: A1
- Application number: 10/635,428
- Filed: 2003-08-06
- Published: 2005-02-10
- Earliest claimed: 2003-08-06
- Inventors: Balaji Venkataraman
- Web page: https://patentgrep.com/patent/US20050032740A1

## CPC

- A61K 31/525: Isoalloxazines, e.g. riboflavins, vitamin B2
- A61K 31/355: Tocopherols, e.g. vitamin E
- A61K 31/714: Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Provided are vitamin compositions and methods for the treatment of dementia and vascular diseases, including cardiovascular diseases. The vitamin compositions comprise vitamin B12, vitamin B6, folic acid, magnesium and vitamin E.

## Claims

### Claim 1

A composition comprising vitamin B12, vitamin B6, folic acid, magnesium, and vitamin E.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the magnesium is in an amount between about 50 mg and 350 mg.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the vitamin E is an amount less than 400 IU.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the vitamin E is in an amount between about 50 IU and 350 IU.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the folic acid is in an amount between about 0.8 mg and 5 mg.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the vitamin B12 is hydroxocobalamin.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the hydroxocobalamin is in an amount between about 300 mcg and 2000 mcg.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the vitamin B12 is cyanocobalamin.

### Claim 9 (depends on 8)

The composition of claim 8, wherein the cyanocobalamin is in an amount between about 300 mcg and 2000 mcg.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the vitamin B12 is a mixture of cyanocobalamin and hydroxocobalamin.

### Claim 11 (depends on 10)

The composition of claim 10, wherein the cyanocobalamin is in an amount of between about 300 mcg and 2000 mcg and the hydroxocobalamin is in an amount of between about 300 mcg and 2000 mcg, provided the amount of cyanocobalamin and the amount of hydroxocobalamin does not exceed 2000 mcg.

### Claim 12 (depends on 1)

The composition of claim 1, wherein the vitamin B6 is in an amount of between about 10 mg and 100 mg.

### Claim 13 (depends on 1)

The composition of claim 1, wherein magnesium is in an amount between about 50 mg and 350 mg, vitamin E is in an amount between about 50 IU and 400 IU, folic acid is in an amount between about 0.8 mg and 5 mg, vitamin B12 is in an amount between about 300 mcg and 2000 mcg, and vitamin B6 is in an amount between about 10 mg and 100 mg.

### Claim 14 (depends on 1)

The composition of claim 1, wherein magnesium is in an amount of about 100 mg, vitamin E is in an amount of about 100 IU, folic acid is in an amount of about 2.05 mg, vitamin B12 is in an amount of about 500 mcg, and vitamin B6 is in an amount of about 25 mg.

### Claim 15 (depends on 1)

The composition of claim 1 further comprising niacin.

### Claim 16 (depends on 15)

The composition of claim 15, wherein the niacin is in an amount less than 250 mg.

### Claim 17 (depends on 15)

The composition of claim 15, wherein the niacin is an amount of about 35 mg.

### Claim 18

A method of treating or preventing a vascular disease or dementia in a human comprising administering to the human an amount of a composition comprising vitamin B12, vitamin B6, folic acid, magnesium and vitamin E, wherein the amount is effective to treat or prevent the vascular disease or the dementia in the human.

### Claim 19 (depends on 18)

The method of claim 18, wherein the vitamin B12 is hydroxocobalamin.

### Claim 20 (depends on 18)

The method of claim 18, wherein the vitamin B12 is cyanocobalamin.

### Claim 21 (depends on 18)

The method of claim 18, wherein magnesium is in an amount between about 50 mg and 350 mg, vitamin E is in an amount between about 50 IU and 400 IU, folic acid is in an amount between about 0.8 mg and 5 mg, vitamin B12 is in an amount between about 300 mcg and 2000 mcg, and vitamin B6 is in an amount between about 10 mg and 100 mg.

### Claim 22 (depends on 18)

The method of claim 18, wherein magnesium is in an amount of about 100 mg, vitamin E is in an amount of about 100 IU, folic acid is in an amount of about 2.05 mg, vitamin B12 is in an amount of about 500 mcg, and vitamin B6 is in an amount of about 25 mg.

### Claim 23 (depends on 18)

The method of claim 18, wherein the composition further comprises niacin.

### Claim 24 (depends on 18)

The method of claim 18, wherein the vascular disease is a cardiovascular disease, cerebrovascular disease, peripheral vascular disease, an atherosclerotic vascular disease or an arteriosclerotic vascular disease.

### Claim 25 (depends on 18)

The method of claim 18, wherein the vascular disease is a cardiovascular disease.

### Claim 26

A composition comprising hydroxocobalamin, vitamin B6, folic acid, magnesium, and vitamin E.

### Claim 27

A method of treating or preventing a vascular disease or dementia in a human comprising administering to the human an amount of a composition comprising hydroxocobalamin, vitamin B6, folic acid, magnesium and vitamin E, wherein the amount is effective to treat or prevent the vascular disease or the dementia in the human.
